Laura Wake
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Genetic and rare skin diseases. 1
-
- Immunodeficiency and Autoimmune Disorders 4
- Biomarkers in Disease Mechanisms 1
- Co-authors
- Mark Raffeld (2 shared papers)Liqiang Xi (2 shared papers)Sarah E. M. Herman (1 shared paper)Maryalice Stetler‐Stevenson (2 shared papers)Adrian Wiestner (2 shared papers)Maher Albitar (1 shared paper)Adam Albitar (1 shared paper)Janet Valdez (1 shared paper)
- Journals
- American Journal of Clinical Pathology (3 papers)Blood (2 papers)Transplantation and Cellular Therapy (1 paper)Journal of Clinical Pathology (1 paper)Diagnostic Cytopathology (1 paper)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Laura Wake
16 papers receiving 276 citations
Peers
Comparison fields: 5 of 39
- Genetics 226
- Pathology and Forensic Medicine 168
- Immunology 92
- Hematology 48
- Oncology 38
Countries citing papers authored by Laura Wake
This map shows the geographic impact of Laura Wake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Wake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Wake more than expected).
Fields of papers citing papers by Laura Wake
This network shows the impact of papers produced by Laura Wake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Wake. The network helps show where Laura Wake may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Wake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 237 | |
| 2 | 2013 | 11 | |
| 3 | 2018 | 6 | |
| 4 | 2019 | 6 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2013 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2012 | 0 | |
| 18 | 2024 | 0 |
About Laura Wake
Laura Wake is a scholar working on Genetics, Immunology, Hematology, Pathology and Forensic Medicine and Rheumatology, having authored 18 papers that have together received 280 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Acute Myeloid Leukemia Research (1 paper), Biomarkers in Disease Mechanisms (1 paper) and Genetic and rare skin diseases. (1 paper). The work is most often cited by research in Genetics (226 citations), Pathology and Forensic Medicine (168 citations), Immunology (92 citations), Hematology (48 citations) and Oncology (38 citations). Laura Wake has collaborated with scholars based in United States, China and India. Frequent co-authors include Mark Raffeld, Liqiang Xi, Sarah E. M. Herman, Maryalice Stetler‐Stevenson, Adrian Wiestner, Maher Albitar, Adam Albitar, Janet Valdez, Constance M. Yuan and Inhye E. Ahn. Their work appears in journals such as American Journal of Clinical Pathology, Blood, Transplantation and Cellular Therapy, Journal of Clinical Pathology and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.